Boiron Financial Statements From 2010 to 2024

BON Stock  EUR 29.60  0.10  0.34%   
Boiron SA financial statements provide useful quarterly and yearly information to potential Boiron SA investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Boiron SA financial statements helps investors assess Boiron SA's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Boiron SA's valuation are summarized below:
Boiron SA does not presently have any fundamental signals for analysis.
Check Boiron SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boiron SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Boiron financial statements analysis is a perfect complement when working with Boiron SA Valuation or Volatility modules.
  
This module can also supplement various Boiron SA Technical models . Check out the analysis of Boiron SA Correlation against competitors.

Boiron SA Company Operating Margin Analysis

Boiron SA's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Boiron SA Operating Margin

    
  0.15 %  
Most of Boiron SA's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Boiron SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Boiron SA has an Operating Margin of 0.147%. This is 100.42% lower than that of the Healthcare sector and 99.27% lower than that of the Drug Manufacturers - Major industry. The operating margin for all Germany stocks is 102.67% lower than that of the firm.

Boiron SA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Boiron SA's current stock value. Our valuation model uses many indicators to compare Boiron SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Boiron SA competition to find correlations between indicators driving Boiron SA's intrinsic value. More Info.
Boiron SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.65  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Boiron SA is roughly  1.55 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Boiron SA's earnings, one of the primary drivers of an investment's value.

About Boiron SA Financial Statements

Boiron SA stakeholders use historical fundamental indicators, such as Boiron SA's revenue or net income, to determine how well the company is positioned to perform in the future. Although Boiron SA investors may analyze each financial statement separately, they are all interrelated. For example, changes in Boiron SA's assets and liabilities are reflected in the revenues and expenses on Boiron SA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Boiron SA. Please read more on our technical analysis and fundamental analysis pages.
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. Boiron SA was founded in 1932 and is headquartered in Messimy, France. BOIRON SA operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3084 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Boiron Stock

Boiron SA financial ratios help investors to determine whether Boiron Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boiron with respect to the benefits of owning Boiron SA security.